Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1039, 2005-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Health Canada suspends Adderall, US FDA advises caution
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
Access to resources
Recommend
US FDA advises caution for recombinant erythropoietins
Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. :
US FDA advises caution for recombinant erythropoietins
Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. :
Health Canada advises of health risks with benzocaine
Reactions Weekly, Vol. 1, Iss. 1130, 2006-01 ,pp. :
Health Canada advises of health risks with EMPowerplus
Reactions Weekly, Vol. 1, Iss. 1142, 2007-01 ,pp. :